Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2018-10-07
2019-07-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Theta Connectivity in Working Memory
NCT05204381
Causal Role of Frontostriatal Circuitry in Goal-directed Behavior
NCT05593965
Modulation of Brain Oscillations Underlying Working Memory
NCT05923606
Using Electroencephalography (EEG) and Transcranial Current Stimulation (tCS) to Study and Modulate Cognition Study
NCT03293316
Atlas of Intracranial Recordings on Cortical Responses After Functional tACS
NCT04560959
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Theta-gamma, Delta-beta, Sham
Every participant will receive Theta-gamma tACS, Delta-beta tACS, and Sham tACS on separate sessions during performance of a computerized task.
Sequence: Theta-gamma tACS, then Delta-beta tACS, then Sham tACS
Theta-gamma tACS
NeuroConn technologies, direct current-stimulator plus
Delta-beta tACS
NeuroConn technologies, direct current-stimulator plus
Sham tACS
NeuroConn technologies, direct current-stimulator plus
Theta-gamma, Sham, Delta-beta
Every participant will receive Theta-gamma tACS, Delta-beta tACS, and Sham tACS on separate sessions during performance of a computerized task.
Sequence: Theta-gamma tACS, then Sham tACS, then Delta-beta tACS
Theta-gamma tACS
NeuroConn technologies, direct current-stimulator plus
Delta-beta tACS
NeuroConn technologies, direct current-stimulator plus
Sham tACS
NeuroConn technologies, direct current-stimulator plus
Delta-beta, Theta-gamma, Sham tACS
Every participant will receive Theta-gamma tACS, Delta-beta tACS, and Sham tACS on separate sessions during performance of a computerized task.
Sequence: Delta-beta tACS, then Theta-gamma tACS, then Sham tACS
Theta-gamma tACS
NeuroConn technologies, direct current-stimulator plus
Delta-beta tACS
NeuroConn technologies, direct current-stimulator plus
Sham tACS
NeuroConn technologies, direct current-stimulator plus
Delta-beta, Sham, Theta-gamma tACS
Every participant will receive Theta-gamma tACS, Delta-beta tACS, and Sham tACS on separate sessions during performance of a computerized task.
Sequence: Delta-beta tACS, then Sham tACS, then Theta-gamma tACS
Theta-gamma tACS
NeuroConn technologies, direct current-stimulator plus
Delta-beta tACS
NeuroConn technologies, direct current-stimulator plus
Sham tACS
NeuroConn technologies, direct current-stimulator plus
Sham, Delta-beta, Theta-gamma tACS
Every participant will receive Theta-gamma tACS, Delta-beta tACS, and Sham tACS on separate sessions during performance of a computerized task.
Sequence: Sham tACS, then Delta-beta tACS, then Theta-gamma tACS
Theta-gamma tACS
NeuroConn technologies, direct current-stimulator plus
Delta-beta tACS
NeuroConn technologies, direct current-stimulator plus
Sham tACS
NeuroConn technologies, direct current-stimulator plus
Sham, Theta-gamma, Delta-beta tACS
Every participant will receive Theta-gamma tACS, Delta-beta tACS, and Sham tACS on separate sessions during performance of a computerized task.
Sequence: Sham tACS, then Theta-gamma tACS, then Delta-beta tACS
Theta-gamma tACS
NeuroConn technologies, direct current-stimulator plus
Delta-beta tACS
NeuroConn technologies, direct current-stimulator plus
Sham tACS
NeuroConn technologies, direct current-stimulator plus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Theta-gamma tACS
NeuroConn technologies, direct current-stimulator plus
Delta-beta tACS
NeuroConn technologies, direct current-stimulator plus
Sham tACS
NeuroConn technologies, direct current-stimulator plus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide informed consent
* Willing to comply with all study procedures and be available for the duration of the study Speak and understand English
Exclusion Criteria
* Neurological disorders and conditions, including, but not limited to:
* History of epilepsy
* Seizures (except childhood febrile seizures and electroconvulsive therapy induced seizures) Dementia
* History of stroke
* Parkinson's disease
* Multiple sclerosis
* Cerebral aneurysm
* Brain tumors
* Medical or neurological illness or treatment for a medical disorder that could interfere with study participation (e.g., unstable cardiac disease, malignancy)
* Prior brain surgery
* Any brain devices/implants, including cochlear implants and aneurysm clips
* History or current traumatic brain injury
* (For females) Pregnancy or breast feeding
* Personal or family history of mental/psychiatric disorder (e.g., anxiety, major depressive disorder, schizophrenia, etc.)
* Positive urine test for the following: Marijuana (THC), Cocaine (COC), Phencyclidine (PCP), Amphetamine (AMP), Ecstasy (MDMA), Methamphetamine (Mamp), Opiates (OPI), Oxycodone (OXY), Methadone (MTD), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Tricyclic Antidepressants (TCA), Propoxyphene (PPX)
* Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Flavio Frohlich, PhD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Riddle J, McFerren A, Frohlich F. Causal role of cross-frequency coupling in distinct components of cognitive control. Prog Neurobiol. 2021 Jul;202:102033. doi: 10.1016/j.pneurobio.2021.102033. Epub 2021 Mar 16.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-0003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.